Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 463 entries
Sorted by: Best Match Show Resources per page
[Medicine of tomorrow and the role of nurses--expectation of a physician].

[Kango gijutsu] : [Nursing technique]

Okajima S.
PMID: 3844525
Kango Gijutsu. 1985 Jan;31(2):255-61.

No abstract available.

Cite
Okajima S. [Medicine of tomorrow and the role of nurses--expectation of a physician]. Kango Gijutsu. 1985;31(2):255-61
Okajima, S. (1985). [Medicine of tomorrow and the role of nurses--expectation of a physician]. [Kango gijutsu] : [Nursing technique], 31(2), 255-61.
Okajima, S. "[Medicine of tomorrow and the role of nurses--expectation of a physician]." [Kango gijutsu] : [Nursing technique] vol. 31,2 (1985): 255-61.
Okajima S. [Medicine of tomorrow and the role of nurses--expectation of a physician]. Kango Gijutsu. 1985 Jan;31(2):255-61. Japanese. PMID: 3844525.
Copy Download .nbib Format: NLM
Efficiency and validity of abbreviated ECG lead system composed of leads aVf, V1 and V5 as a screening test.

Annual report of the Research Institute of Environmental Medicine, Nagoya University

Yamada K, Okajima M, Okamoto N, Hori K, Kamijo M.
PMID: 5385340
Annu Rep Res Inst Environ Med Nagoya Univ. 1969;17:15-24.

No abstract available.

Cite
Yamada K, Okajima M, Okamoto N, et al. Efficiency and validity of abbreviated ECG lead system composed of leads aVf, V1 and V5 as a screening test. Annu Rep Res Inst Environ Med Nagoya Univ. 1969;17:15-24
Yamada, K., Okajima, M., Okamoto, N., Hori, K., & Kamijo, M. (1969). Efficiency and validity of abbreviated ECG lead system composed of leads aVf, V1 and V5 as a screening test. Annual report of the Research Institute of Environmental Medicine, Nagoya University, 1715-24.
Yamada, K, et al. "Efficiency and validity of abbreviated ECG lead system composed of leads aVf, V1 and V5 as a screening test." Annual report of the Research Institute of Environmental Medicine, Nagoya University vol. 17 (1969): 15-24.
Yamada K, Okajima M, Okamoto N, Hori K, Kamijo M. Efficiency and validity of abbreviated ECG lead system composed of leads aVf, V1 and V5 as a screening test. Annu Rep Res Inst Environ Med Nagoya Univ. 1969;17:15-24. PMID: 5385340.
Copy Download .nbib Format: NLM
[Test for the resolving power of the magnifying radiography tube].

Rinsho hoshasen. Clinical radiography

Okajima S.
PMID: 5204659
Rinsho Hoshasen. 1971 Jan;16(1):40.

No abstract available.

Cite
Okajima S. [Test for the resolving power of the magnifying radiography tube]. Rinsho Hoshasen. 1971;16(1):40
Okajima, S. (1971). [Test for the resolving power of the magnifying radiography tube]. Rinsho hoshasen. Clinical radiography, 16(1), 40.
Okajima, S. "[Test for the resolving power of the magnifying radiography tube]." Rinsho hoshasen. Clinical radiography vol. 16,1 (1971): 40.
Okajima S. [Test for the resolving power of the magnifying radiography tube]. Rinsho Hoshasen. 1971 Jan;16(1):40. Japanese. PMID: 5204659.
Copy Download .nbib Format: NLM
Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species.

ZooKeys

Tsujii K, Mita T, Terayama M, Pham HT, Okajima S.
PMID: 26155069
Zookeys. 2015 Jun 08;(507):25-30. doi: 10.3897/zookeys.507.9773. eCollection 2015.

Formosiepyrisvietnamensis sp. n. (Hymenoptera: Bethylidae) is described based on material collected from Da Lat, southern Vietnam. This is the first record of Formosiepyris Terayama from Vietnam. The new species can be distinguished from other Formosiepyris species by a narrow...

Cite
Tsujii K, Mita T, Terayama M, et al. Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. Zookeys. 2015;(507):25-30doi: 10.3897/zookeys.507.9773.
Tsujii, K., Mita, T., Terayama, M., Pham, H. T., & Okajima, S. (2015). Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. ZooKeys, (507), 25-30. https://doi.org/10.3897/zookeys.507.9773
Tsujii, Kentaro, et al. "Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species." ZooKeys vol. ,507 (2015): 25-30. doi: https://doi.org/10.3897/zookeys.507.9773
Tsujii K, Mita T, Terayama M, Pham HT, Okajima S. Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. Zookeys. 2015 Jun 08;(507):25-30. doi: 10.3897/zookeys.507.9773. eCollection 2015. PMID: 26155069; PMCID: PMC4490217.
Copy Download .nbib Format: NLM
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.

Physiological reports

Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F.
PMID: 26660549
Physiol Rep. 2015 Dec;3(12). doi: 10.14814/phy2.12628.

Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. Inflammation plays an integral role in the development of pulmonary fibrosis. Unresolved inflammatory responses can lead to substantial tissue injury, chronic inflammation, and fibrosis. The resolvins...

Cite
Yatomi M, Hisada T, Ishizuka T, et al. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep. 2015;3(12)doi: 10.14814/phy2.12628.
Yatomi, M., Hisada, T., Ishizuka, T., Koga, Y., Ono, A., Kamide, Y., Seki, K., Aoki-Saito, H., Tsurumaki, H., Sunaga, N., Kaira, K., Dobashi, K., Yamada, M., & Okajima, F. (2015). 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiological reports, 3(12), . https://doi.org/10.14814/phy2.12628
Yatomi, Masakiyo, et al. "17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice." Physiological reports vol. 3,12 (2015). doi: https://doi.org/10.14814/phy2.12628
Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep. 2015 Dec;3(12). doi: 10.14814/phy2.12628. PMID: 26660549; PMCID: PMC4760456.
Copy Download .nbib Format: NLM
Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand.

Inorganic chemistry

Kojima T, Ogishima F, Nishibu T, Kotani H, Ishizuka T, Okajima T, Nozawa S, Shiota Y, Yoshizawa K, Ohtsu H, Kawano M, Shiga T, Oshio H.
PMID: 29547281
Inorg Chem. 2018 Aug 20;57(16):9683-9695. doi: 10.1021/acs.inorgchem.8b00037. Epub 2018 Mar 16.

An iron(III) complex having a dibenzotetraethyltetraamido macrocyclic ligand (DTTM

Cite
Kojima T, Ogishima F, Nishibu T, et al. Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorg Chem. 2018;57(16):9683-9695doi: 10.1021/acs.inorgchem.8b00037.
Kojima, T., Ogishima, F., Nishibu, T., Kotani, H., Ishizuka, T., Okajima, T., Nozawa, S., Shiota, Y., Yoshizawa, K., Ohtsu, H., Kawano, M., Shiga, T., & Oshio, H. (2018). Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorganic chemistry, 57(16), 9683-9695. https://doi.org/10.1021/acs.inorgchem.8b00037
Kojima, Takahiko, et al. "Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand." Inorganic chemistry vol. 57,16 (2018): 9683-9695. doi: https://doi.org/10.1021/acs.inorgchem.8b00037
Kojima T, Ogishima F, Nishibu T, Kotani H, Ishizuka T, Okajima T, Nozawa S, Shiota Y, Yoshizawa K, Ohtsu H, Kawano M, Shiga T, Oshio H. Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorg Chem. 2018 Aug 20;57(16):9683-9695. doi: 10.1021/acs.inorgchem.8b00037. Epub 2018 Mar 16. PMID: 29547281.
Copy Download .nbib Format: NLM
Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant.

Journal of diabetes investigation

Nagao M, Asai A, Kawahara M, Nakajima Y, Sato Y, Tanimura K, Okajima F, Takaya M, Sudo M, Takemitsu S, Harada T, Sugihara H, Oikawa S.
PMID: 24843572
J Diabetes Investig. 2012 Jun 06;3(3):245-51. doi: 10.1111/j.2040-1124.2011.00175.x.

UNLABELLED: Aims/Introduction:  The development of type 2 diabetes is primarily due to lifestyle and environmental factors, as well as genetics, as shown by familial clustering. To establish mouse lines for evaluating heritable factors determining susceptibility to diet-induced diabetes, we...

Cite
Nagao M, Asai A, Kawahara M, et al. Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant. J Diabetes Investig. 2012;3(3):245-51doi: 10.1111/j.2040-1124.2011.00175.x.
Nagao, M., Asai, A., Kawahara, M., Nakajima, Y., Sato, Y., Tanimura, K., Okajima, F., Takaya, M., Sudo, M., Takemitsu, S., Harada, T., Sugihara, H., & Oikawa, S. (2012). Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant. Journal of diabetes investigation, 3(3), 245-51. https://doi.org/10.1111/j.2040-1124.2011.00175.x
Nagao, Mototsugu, et al. "Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant." Journal of diabetes investigation vol. 3,3 (2012): 245-51. doi: https://doi.org/10.1111/j.2040-1124.2011.00175.x
Nagao M, Asai A, Kawahara M, Nakajima Y, Sato Y, Tanimura K, Okajima F, Takaya M, Sudo M, Takemitsu S, Harada T, Sugihara H, Oikawa S. Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant. J Diabetes Investig. 2012 Jun 06;3(3):245-51. doi: 10.1111/j.2040-1124.2011.00175.x. PMID: 24843572; PMCID: PMC4014945.
Copy Download .nbib Format: NLM
Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes.

Journal of diabetes investigation

Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura-Inagaki K, Okajima F, Tamura H, Inazawa T, Otonari T, Kawakami M, Oikawa S.
PMID: 24843762
J Diabetes Investig. 2014 Mar 23;5(2):206-12. doi: 10.1111/jdi.12135. Epub 2013 Oct 25.

AIMS/INTRODUCTION: α-Glucosidase inhibitors (αGIs) are widely used for the primary treatment of type 2 diabetes. We compared the clinical effects of three αGIs (miglitol, acarbose and voglibose) in patients with obese type 2 diabetes.MATERIALS AND METHODS: Japanese patients (n...

Cite
Sugihara H, Nagao M, Harada T, et al. Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes. J Diabetes Investig. 2013;5(2):206-12doi: 10.1111/jdi.12135.
Sugihara, H., Nagao, M., Harada, T., Nakajima, Y., Tanimura-Inagaki, K., Okajima, F., Tamura, H., Inazawa, T., Otonari, T., Kawakami, M., & Oikawa, S. (2014). Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes. Journal of diabetes investigation, 5(2), 206-12. https://doi.org/10.1111/jdi.12135
Sugihara, Hitoshi, et al. "Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes." Journal of diabetes investigation vol. 5,2 (2014): 206-12. doi: https://doi.org/10.1111/jdi.12135
Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura-Inagaki K, Okajima F, Tamura H, Inazawa T, Otonari T, Kawakami M, Oikawa S. Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes. J Diabetes Investig. 2014 Mar 23;5(2):206-12. doi: 10.1111/jdi.12135. Epub 2013 Oct 25. PMID: 24843762; PMCID: PMC4023585.
Copy Download .nbib Format: NLM
A Ruthenium(III)-Oxyl Complex Bearing Strong Radical Character.

Angewandte Chemie (International ed. in English)

Shimoyama Y, Ishizuka T, Kotani H, Shiota Y, Yoshizawa K, Mieda K, Ogura T, Okajima T, Nozawa S, Kojima T.
PMID: 27709765
Angew Chem Int Ed Engl. 2016 Nov 02;55(45):14041-14045. doi: 10.1002/anie.201607861. Epub 2016 Oct 06.

Proton-coupled electron-transfer oxidation of a Ru

Cite
Shimoyama Y, Ishizuka T, Kotani H, et al. A Ruthenium(III)-Oxyl Complex Bearing Strong Radical Character. Angew Chem Int Ed Engl. 2016;55(45):14041-14045doi: 10.1002/anie.201607861.
Shimoyama, Y., Ishizuka, T., Kotani, H., Shiota, Y., Yoshizawa, K., Mieda, K., Ogura, T., Okajima, T., Nozawa, S., & Kojima, T. (2016). A Ruthenium(III)-Oxyl Complex Bearing Strong Radical Character. Angewandte Chemie (International ed. in English), 55(45), 14041-14045. https://doi.org/10.1002/anie.201607861
Shimoyama, Yoshihiro, et al. "A Ruthenium(III)-Oxyl Complex Bearing Strong Radical Character." Angewandte Chemie (International ed. in English) vol. 55,45 (2016): 14041-14045. doi: https://doi.org/10.1002/anie.201607861
Shimoyama Y, Ishizuka T, Kotani H, Shiota Y, Yoshizawa K, Mieda K, Ogura T, Okajima T, Nozawa S, Kojima T. A Ruthenium(III)-Oxyl Complex Bearing Strong Radical Character. Angew Chem Int Ed Engl. 2016 Nov 02;55(45):14041-14045. doi: 10.1002/anie.201607861. Epub 2016 Oct 06. PMID: 27709765.
Copy Download .nbib Format: NLM
Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy.

Journal of cardiovascular electrophysiology

Chimura M, Kiuchi K, Okajima K, Shimane A, Sawada T, Onishi T, Yamada S, Taniguchi Y, Yasaka Y, Kawai H.
PMID: 26223827
J Cardiovasc Electrophysiol. 2015 Nov;26(11):1239-1246. doi: 10.1111/jce.12767. Epub 2015 Sep 10.

BACKGROUND: Current guidelines recommend the implantation of an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) in a subgroup of patients with nonischemic cardiomyopathy (NICM) who have a left ventricular ejection fraction (LVEF) ≤ 30-35%, and...

Cite
Chimura M, Kiuchi K, Okajima K, et al. Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy. J Cardiovasc Electrophysiol. 2015;26(11):1239-1246doi: 10.1111/jce.12767.
Chimura, M., Kiuchi, K., Okajima, K., Shimane, A., Sawada, T., Onishi, T., Yamada, S., Taniguchi, Y., Yasaka, Y., & Kawai, H. (2015). Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy. Journal of cardiovascular electrophysiology, 26(11), 1239-1246. https://doi.org/10.1111/jce.12767
Chimura, Misato, et al. "Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy." Journal of cardiovascular electrophysiology vol. 26,11 (2015): 1239-1246. doi: https://doi.org/10.1111/jce.12767
Chimura M, Kiuchi K, Okajima K, Shimane A, Sawada T, Onishi T, Yamada S, Taniguchi Y, Yasaka Y, Kawai H. Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy. J Cardiovasc Electrophysiol. 2015 Nov;26(11):1239-1246. doi: 10.1111/jce.12767. Epub 2015 Sep 10. PMID: 26223827.
Copy Download .nbib Format: NLM
Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis.

Restorative neurology and neuroscience

Thanos PK, Okajima S, Tiangco DA, Terzis JK.
PMID: 12671244
Restor Neurol Neurosci. 1999;15(1):57-71.

Among the pathological sequelae of facial paralysis is a paralytic eye. Apart from the psychological and aesthetic deficits, facial paralysis if left untreated can lead to dryness, ulceration and eventual blindness. Although numerous restorative microsurgical approaches have been introduced...

Cite
Thanos PK, Okajima S, Tiangco DA, et al. Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis. Restor Neurol Neurosci. 1999;15(1):57-71
Thanos, P. K., Okajima, S., Tiangco, D. A., & Terzis, J. K. (1999). Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis. Restorative neurology and neuroscience, 15(1), 57-71.
Thanos, Panayotis K., et al. "Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis." Restorative neurology and neuroscience vol. 15,1 (1999): 57-71.
Thanos PK, Okajima S, Tiangco DA, Terzis JK. Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis. Restor Neurol Neurosci. 1999;15(1):57-71. PMID: 12671244.
Copy Download .nbib Format: NLM
Synthesis and redox behavior of azulene-substituted benzene derivatives and (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes.

The Journal of organic chemistry

Ito S, Inabe H, Okujima T, Morita N, Watanabe M, Harada N, Imafuku K.
PMID: 11597235
J Org Chem. 2001 Oct 19;66(21):7090-101. doi: 10.1021/jo010540u.

1,2-Di(6-azulenyl)tetraphenylbenzenes and (6-azulenyl)pentaphenylbenzenes were synthesized by Diels-Alder reactions of di(6-azulenyl)acetylenes and 6-(phenylethynyl)azulenes with tetraphenylcyclopentadienone. Cobalt-mediated cyclooligomerization of mono- and di(6-azulenyl)acetylenes afforded 1,3,5- and 1,2,4-tri(6-azulenyl)benzene derivatives together with (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes. The redox behavior of these novel (6-azulenyl)benzene derivatives...

Cite
Ito S, Inabe H, Okujima T, et al. Synthesis and redox behavior of azulene-substituted benzene derivatives and (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes. J Org Chem. 2001;66(21):7090-101doi: 10.1021/jo010540u.
Ito, S., Inabe, H., Okujima, T., Morita, N., Watanabe, M., Harada, N., & Imafuku, K. (2001). Synthesis and redox behavior of azulene-substituted benzene derivatives and (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes. The Journal of organic chemistry, 66(21), 7090-101. https://doi.org/10.1021/jo010540u
Ito, S, et al. "Synthesis and redox behavior of azulene-substituted benzene derivatives and (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes." The Journal of organic chemistry vol. 66,21 (2001): 7090-101. doi: https://doi.org/10.1021/jo010540u
Ito S, Inabe H, Okujima T, Morita N, Watanabe M, Harada N, Imafuku K. Synthesis and redox behavior of azulene-substituted benzene derivatives and (eta(5)-cyclopentadienyl)[tetra- and di(6-azulenyl)cyclobutadiene]cobalt complexes. J Org Chem. 2001 Oct 19;66(21):7090-101. doi: 10.1021/jo010540u. PMID: 11597235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 463 entries